OTLC
Trieu Vuong, OTLC's CEO, spent $520 of their own money on 104,000 shares at $0.
+$520
104,000 sh @ $0
OTLC
Oncotelic Therapeutics, Inc.
SEC CIK 908259
$0.0500
−28.6% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
25
Most recent
Advertisement
At a glance
Insiders at OTLC have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Trieu Vuong, OTLC's CEO, spent $13K of their own money on 400,000 shares at $0.
Most active filer: Trieu Vuong, with 20 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for OTLC, newest firstOTLC
Trieu Vuong, OTLC's CEO, spent $0 of their own money on 1 shares at $0.
+$0
1 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $474 of their own money on 94,736 shares at $0.
+$474
94,736 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $1.8K of their own money on 63,775 shares at $0.
+$1.8K
63,775 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $2.8K of their own money on 100,003 shares at $0.
+$2.8K
100,003 sh @ $0
Advertisement
OTLC
Trieu Vuong, OTLC's CEO, spent $5.1K of their own money on 183,066 shares at $0.
+$5.1K
183,066 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $8.6K of their own money on 298,499 shares at $0.
+$8.6K
298,499 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $10K of their own money on 500,000 shares at $0, growing their stake 1%.
+$10K
500,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $8.9K of their own money on 425,000 shares at $0.
+$8.9K
425,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $2K of their own money on 75,000 shares at $0.
+$2K
75,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $2.6K of their own money on 100,000 shares at $0.
+$2.6K
100,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $13K of their own money on 400,000 shares at $0.
+$13K
400,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $4.3K of their own money on 126,888 shares at $0.
+$4.3K
126,888 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $4.5K of their own money on 100,000 shares at $0.
+$4.5K
100,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $6K of their own money on 120,000 shares at $0.
+$6K
120,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $5.6K of their own money on 70,000 shares at $0.
+$5.6K
70,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $1.4K of their own money on 20,000 shares at $0.
+$1.4K
20,000 sh @ $0
OTLC
Trieu Vuong, OTLC's CEO, spent $6.6K of their own money on 80,000 shares at $0.
+$6.6K
80,000 sh @ $0
OTLC
+$0
259,302 sh
OTLC
+$0
298,837 sh
OTLC
+$0
102,519 sh
OTLC
+$0
938,646 sh
OTLC
+$0
5.67M sh
OTLC
+$0
3.29M sh
OTLC
+$0
16.35M sh
Advertisement
About OTLC insider activity
This page tracks every recent Form 4 filed for Oncotelic Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is OTLC insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Oncotelic Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.